The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $50.45

Today's change+1.13 +2.29%
Updated December 9 4:04 PM EST. Delayed by at least 15 minutes.
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $50.45

Today's change+1.13 +2.29%
Updated December 9 4:04 PM EST. Delayed by at least 15 minutes.

NU Skin Enterprises Inc up sharply

NU Skin Enterprises Inc closed up sharply Friday, rallying (U.S.)$1.13 or 2.29% to (U.S.)$50.45. Over the last five days, shares are unchanged, but have gained 33.15% over the last year to date. This security has outperformed the S&P 500 by 27.27% during the last year.

Key company metrics

  • Open(U.S.) $49.42
  • Previous close(U.S.) $49.32
  • High(U.S.) $50.67
  • Low(U.S.) $48.96
  • Bid / Ask-- / --
  • YTD % change+33.15%
  • Volume1,107,276
  • Average volume (10-day)1,000,814
  • Average volume (1-month)968,372
  • Average volume (3-month)791,307
  • 52-week range(U.S.) $23.51 to (U.S.) $66.04
  • Beta1.65
  • Trailing P/E20.52×
  • P/E 1 year forward17.00×
  • Forward PEG2.24×
  • Indicated annual dividend(U.S.) $1.42
  • Dividend yield2.81%
  • Trailing EPS(U.S.) $2.46
Updated December 9 4:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.26%

Based on its net profit margin of 6.26%, NU Skin Enterprises Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.11%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue604600472572
Total other revenue--------
Total revenue604600472572
Gross profit478472334451
Total cost of revenue126128138121
Total operating expense522521464510
Selling / general / administrative396392326389
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income8280862
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax7769558
Income after tax5745336
Income tax, total2024223
Net income5745336
Total adjustments to net income--------
Net income before extra. items5745336
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5745336
Inc. avail. to common incl. extra. items5745336
Diluted net income5745336
Dilution adjustment--------
Diluted weighted average shares58565658
Diluted EPS excluding extraordinary itemsvalue per share0.980.790.060.62
Dividends per sharevalue per share0.360.360.360.35
Diluted normalized EPSvalue per share0.980.790.060.62